Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine.

The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.

Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone.

PURPOSE: To report the clinical outcomes of local treatment of toxoplasmic retinochoroiditis (TRC) with intravitreal injections of clindamycin and dexamethasone. STUDY POPULATION: 16 eyes (16 patients) with active TRC sparing the macula and juxtapapillary area treated with intravitreal injections of clindamycin (1 mg) and dexamethasone (1 mg) without concomitant systemic antitoxoplasmic or anti-inflammatory therapy. Measured parameters: Best-corrected visual acuity (BCVA) was measured by an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. BCVA and clinical characteristics of retinochoroiditis were assessed at baseline and at 1, 3, 6, and 12 months. PRIMARY OUTCOME MEASURES: Resolution of retinochoroiditis and changes in BCVA. RESULTS: Control of TRC was achieved in all cases with a mean interval of 2.48 ± 1.03 weeks (2-6 weeks). A single injection of intravitreal clindamycin and dexamethasone was performed in 12 patients, and four patients required two intravitreal injections, during the follow-up period. Fourteen eyes (87.5%) improved ≥ 2 ETDRS lines of BCVA, of two or more Early Treatment Diabetic Retinopathy Study lines, BCVA remained stable in two eyes (12.5%), and no patient had decreased BCVA at the end of the follow-up period. No ocular or systemic adverse events were observed. CONCLUSION: Local treatment with intravitreal injections of clindamycin and dexamethasone without concomitant systemic therapy was associated with resolution of TRC in patients without macular or juxtapapillary involvement. Intravitreal clindamycin and dexamethasone may represent a viable treatment option in patients with allergies or inadequate responses to oral medications.

Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

PURPOSE: To describe the features and outcomes of patients with AIDS-related cytomegalovirus retinitis after highly active antiretroviral therapy availability. METHODS: Retrospective chart review of 30 consecutive patients (44 eyes) with AIDS and newly diagnosed, active AIDS-related cytomegalovirus retinitis, examined from January 2005 to December 2007. RESULTS: The mean age was 34.8 years, 18 patients (60.0%) were male and median duration of AIDS was 90 months. Nineteen patients (63.3%) had evidence of highly active antiretroviral therapy failure and median CD4+ lymphocyte count was 12.5 cells/microl. Visual acuity at presentation was 20/40 or better in 27 eyes (61.4%). Retinitis involved Zone 1 in 13 eyes (39.5%). Despite specific anti-AIDS-related cytomegalovirus therapy, 16 eyes (36.4%) presented relapse of retinitis and 10 eyes (22.7%) lost at least three lines of vision. When compared to highly active antiretroviral therapy responsive patients, eyes of highly active antiretroviral therapy failure patients were more likely to develop relapse of retinitis (p=0.03) and loss of at least three lines of vision (p=0.03). CONCLUSION: The patients in this series are essentially young men with longstanding AIDS, non-responsive to highly active antiretroviral therapy and with a similar immunological profile as noted before highly active antiretroviral therapy era. These findings have implications for the management of the disease and confirm the magnitude of rational periodic screening after diagnosis of AIDS.

Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone / Tratamento local para a retinocoroidite toxoplásmica com clindamicina e dexametasona intravítrea

ABSTRACTPurpose:To report the clinical outcomes of local treatment of toxoplasmic retinochoroiditis (TRC) with intravitreal injections of clindamycin and dexamethasone.Methods:Study population: 16 eyes (16 patients) with active TRC sparing the macula and juxtapapillary area treated with intravitreal injections of clindamycin (1 mg) and dexamethasone (1 mg) without concomitant systemic antitoxoplasmic or anti-inflammatory therapy. Measured parameters: Best-corrected visual acuity (BCVA) was measured by an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. BCVA and clinical characteristics of retinochoroiditis were assessed at baseline and at 1, 3, 6, and 12 months. Primary outcome measures: Resolution of retinochoroiditis and changes in BCVA.Results:Control of TRC was achieved in all cases with a mean interval of 2.48 ± 1.03 weeks (2-6 weeks). A single injection of intravitreal clindamycin and dexamethasone was performed in 12 patients, and four patients required two intravitreal injections, during the follow-up period. Fourteen eyes (87.5%) improved ≥ 2 ETDRS lines of BCVA, of two or more Early Treatment Diabetic Retinopathy Study lines, BCVA remained stable in two eyes (12.5%), and no patient had decreased BCVA at the end of the follow-up period. No ocular or systemic adverse events were observed.Conclusion:Local treatment with intravitreal injections of clindamycin and dexamethasone without concomitant systemic therapy was associated with resolution of TRC in patients without macular or juxtapapillary involvement. Intravitreal clindamycin and dexamethasone may represent a viable treatment option in patients with allergies or inadequate responses to oral medications.

RESUMOObjetivo:Reportar os resultados clínicos do tratamento local da retinocoroidite toxoplásmica com injeções intravítreas de clindamicina e dexametasona.Métodos:População do estudo: 16 olhos (16 pacientes) com retinocoroidite toxoplásmica ativa sem comprometimento da mácula e da área juxtapapilar, tratados com injeções intravítreas de clindamicina (1 mg) e dexametasona (1 mg) sem terapia sistêmica anti-toxoplásmica ou anti-inflamatória concomitante. Procedimento de observação: A melhor acuidade visual corrigida (BCVA) foi medida através da tabela ETDRS. A BCVA e as características clínicas da retinocoroidite foram avaliadas na qualificação, primeiro, terceiro, sexto e 12º mês. Medidas do resultado principal: resolução da retinocoroidite e mudanças na BCVA.Resultados:O controle da retinocoroidite toxoplásmica foi atingido em todos os casos com um intervalo médio de 2,48 ± 1,03 semanas (intervalo de 2 a 6 semanas). Uma única injeção intravítrea de clindamicina e dexametasona foi aplicada em 12 pacientes, e quatro pacientes precisaram de duas injeções durante o seguimento. Quatorze olhos (87,5%) melhoraram ≥ 2 linhas ETDRS de BCVA, a BCVA ficou estável em 2 olhos (12,5%) e nenhum paciente apresentou diminuição da acuidade visual no final do seguimento. Não foram observados eventos adversos sistêmicos ou oculares.Conclusão:O tratamento local com injeções intravítreas de clindamicina e dexametasona sem terapia sistêmica concomitante esteve associado com a resolução da retinocoroidite toxoplásmica em pacientes sem comprometimento macular ou juxtapapilar. A clindamicina e dexametasona intravítrea representam um tratamento promissor em pacientes com intolerância, contraindicação ou resposta inadequada a medicação oral.

[Angioid streaks: fundoscopic analysis of 317 cases]. / Estrias angióides: análise fundoscópica de 317 casos.

PURPOSE: To evaluate the presence of choroidal neovascularization (CN) and their sequels in patient bearing angioid streaks (AE). METHODS: Case records of patients assisted from 1976 to 2006 at the Instituto Suel Abujamra located in the city of São Paulo, Brazil, were analyzed retrospectively. Age, skin color; patient complaints at the first evaluation, visual acuity, fundoscopic aspects with special attention to disciform lesions to active or scarred subretinal CN were considered. RESULTS: Among the 317 studied patients, 163 (51.5%) were men. The average age was 57, with standard deviation of 12.4 years, minimum 11 and maximum 91 years. Regarding skin color, 209 (66.2%) were white, 91 (29.0%) were yellow, 11 (3.7%) were black, and 3 (1.1%) were mulatto. AE were bilateral in all patients; of 631 researched eyes, 348 (55.1%) had brown color AE, in 153 (24.2%) they were gray and in 124 (19.6%) reddish brown. Upon diagnosis, visual acuities measured with the Snellen chart were worse than 20/200 in 40.4% of the eyes. CN absence was proven in 103 (32.5%) patients. The unilateral lesions were present in 112 (35.3%) and bilateral lesions were present in 99 (31.2%). Regarding location, 242 (74.3%) were macular, 45 (13.8%) were extramacular and 38 (11.7%) were both macular and extramacular. CONCLUSION: AE are an important cause of legal blindness and can be easily bypassed in an ophthalmic routine examination in the absence of active or disciform neovascular lesions. The expressive number of these cases brings us to the importance of this study. It highlights the need for a meticulous fundoscopic examination in order to improve diagnoses of the disease and early treatment of CN.

Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy / Características e evolução clínica da retinite por citomegalovírus em pacientes com AIDS na era da terapia antirretroviral potente

PURPOSE: To describe the features and outcomes of patients with AIDS-related cytomegalovirus retinitis after highly active antiretroviral therapy availability. METHODS: Retrospective chart review of 30 consecutive patients (44 eyes) with AIDS and newly diagnosed, active AIDS-related cytomegalovirus retinitis, examined from January 2005 to December 2007. RESULTS: The mean age was 34.8 years, 18 patients (60.0 percent) were male and median duration of AIDS was 90 months. Nineteen patients (63.3 percent) had evidence of highly active antiretroviral therapy failure and median CD4+ lymphocyte count was 12.5 cells/µl. Visual acuity at presentation was 20/40 or better in 27 eyes (61.4 percent). Retinitis involved Zone 1 in 13 eyes (39.5 percent). Despite specific anti-AIDSrelated cytomegalovirus therapy, 16 eyes (36.4 percent) presented relapse of retinitis and 10 eyes (22.7 percent) lost at least three lines of vision. When compared to highly active antiretroviral therapy responsive patients, eyes of highly active antiretroviral therapy failure patients were more likely to develop relapse of retinitis (p=0.03) and loss of at least three lines of vision (p=0.03). CONCLUSION: The patients in this series are essentially young men with longstanding AIDS, non-responsive to highly active antiretroviral therapy and with a similar immunological profile as noted before highly active antiretroviral therapy era. These findings have implications for the management of the disease and confirm the magnitude of rational periodic screening after diagnosis of AIDS.

OBJETIVO: Descrever as características e evolução clínica de pacientes com retinite por citomegalovírus relacionada à AIDS após o advento da terapia antirretroviral potente. MÉTODOS: Estudo retrospectivo dos prontuários de 30 pacientes consecutivos (44 olhos) com AIDS e retinite por citomegalovírus ativa recém-diagnosticada, atendidos entre janeiro de 2005 e dezembro de 2007. RESULTADOS: A idade média dos pacientes foi de 34,8 anos, 18 pacientes (60,0 por cento) eram do sexo masculino e a mediana do tempo de diagnóstico de AIDS era 90 meses. Dezenove pacientes (63,3 por cento) apresentavam evidência de falência da terapia antirretroviral potente e a mediana da contagem de linfócitos T CD4+ era 12,5 células/µl. A acuidade visual inicial era melhor ou igual a 20/40 em 27 olhos (61,4 por cento). A retinite acometia a Zona 1 em 13 olhos (39,5 por cento). Apesar da terapia antirretinite por citomegalovírus específica, 16 olhos (36,4 por cento) apresentaram recidiva da retinite e 10 olhos (22,7 por cento) perderam pelo menos três linhas de visão. Quando comparado aos de pacientes com boa resposta à terapia antirretroviral potente, olhos de pacientes com falência à terapia antirretroviral potente apresentaram mais recidiva da retinite (p=0,03) e perda de pelo menos três linhas de visão (p=0,03). CONCLUSÃO: Os pacientes nesta série são essencialmente homens jovens com longo tempo de diagnóstico de AIDS, má resposta à terapia antirretroviral potente e com um perfil imunológico semelhante ao encontrado antes do advento da terapia antirretroviral potente. Estes achados têm implicações no manejo da doença e confirmam a importância da triagem periódica e racional após o diagnóstico de AIDS.

Estrias angióides: análise fundoscópica de 317 casos / Angioid streaks: fundoscopic analysis of 317 cases

OBJETIVO: Avaliar a presença de neovascularização de coróide (NVC) e suas seqüelas em pacientes portadores de estrias angióides (EA). MÉTODOS: Foram analisados retrospectivamente os prontuários de pacientes atendidos no Instituto Suel Abujamra, São Paulo (SP), Brasil, de 1976 a 2006. Considerou-se a idade, cor da pele, queixas na primeira consulta, acuidade visual e aspecto fundoscópico com especial atenção a lesões disciformes por NVC sub-retinianas ativas ou cicatrizadas. RESULTADOS: Dos 317 pacientes estudados, 163 (51,5 por cento) eram homens. A média de idade era de 57 anos com desvio-padrão de 12,4 anos, mínimo de 11 e máximo de 91 anos. Quanto a cor da pele, 209 (66,2 por cento) eram brancos, 91 (29,0 por cento) amarelos,11 (3,7 por cento) negros, e 3 (1,1 por cento) pardos. As EA eram bilaterais em todos os pacientes, e de 631 olhos pesquisados, 348 (55,1 por cento) tinham EA de coloração marrom, 153 (24,2 por cento) cinza e 124 (19,6 por cento) marrom-avermelhada. No momento do diagnóstico, as acuidades visuais medidas na tabela de Snellen foram piores que 20/200 em 40,4 por cento dos olhos. Comprovou-se a ausência de NVC em 103 (32,5 por cento) pacientes. As lesões NVC unilaterais estavam presentes em 112 (35,3 por cento) e bilaterais em 99 (31,2 por cento). Quanto à localização, 242 (74,3 por cento) eram maculares, 45 (13,8 por cento) extra-maculares e 38 (11,7 por cento) mistas. CONCLUSÃO: As EA são importante causa de cegueira legal e podem passar despercebidas no exame oftalmológico de rotina quando não apresentam lesões maculares disciformes ativas ou cicatrizadas. A importância deste estudo é o expressivo número de casos e alertar os oftalmologistas quanto à necessidade de um exame fundoscópico minucioso, a fim de monitorá-las, diagnosticar e tratar precocemente a NVC.

PURPOSE: To evaluate the presence of choroidal neovascularization (CN) and their sequels in patient bearing angioid streaks (AE). METHODS: Case records of patients assisted from 1976 to 2006 at the Instituto Suel Abujamra located in the city of São Paulo, Brazil, were analyzed retrospectively. Age, skin color; patient complaints at the first evaluation, visual acuity, fundoscopic aspects with special attention to disciform lesions to active or scarred subretinal CN were considered. RESULTS: Among the 317 studied patients, 163 (51.5 percent) were men. The average age was 57, with standard deviation of 12.4 years, minimum 11 and maximum 91 years. Regarding skin color, 209 (66.2 percent) were white, 91 (29.0 percent) were yellow, 11 (3.7 percent) were black, and 3 (1.1 percent) were mulatto. AE were bilateral in all patients; of 631 researched eyes, 348 (55.1 percent) had brown color AE, in 153 (24.2 percent) they were gray and in 124 (19.6 percent) reddish brown. Upon diagnosis, visual acuities measured with the Snellen chart were worse than 20/200 in 40.4 percent of the eyes. CN absence was proven in 103 (32.5 percent) patients. The unilateral lesions were present in 112 (35.3 percent) and bilateral lesions were present in 99 (31.2 percent). Regarding location, 242 (74.3 percent) were macular, 45 (13.8 percent) were extramacular and 38 (11.7 percent) were both macular and extramacular. CONCLUSION: AE are an important cause of legal blindness and can be easily bypassed in an ophthalmic routine examination in the absence of active or disciform neovascular lesions. The expressive number of these cases brings us to the importance of this study. It highlights the need for a meticulous fundoscopic examination in order to improve diagnoses of the disease and early treatment of CN.

Estudo da morfologia macular após a remoção da membrana epirretiniana idiopática utilizando a tomografia de coerência óptica (OCT): um estudo piloto / Study on macular morphology after removal of the idiopathic epiretinal membrane using the optical coherence tomography (OCT): a pilot study

OBJETIVO: Descrever a relação entre os resultados visuais e a morfologia macular através da tomografia de coerência óptica (OCT) em pacientes submetidos à remoção da membrana epirretiniana idiopática. MÉTODOS: Dez olhos de 10 pacientes com diagnóstico de membrana epirretiniana idiopática foram incluídos neste estudo. Todos os olhos foram submetidos à vitrectomia posterior via pars plana pelo mesmo cirurgião, durante o período de fevereiro de 2002 a março de 2004. A acuidade visual corrigida usando a tabela de Snellen, bem como a retinografia, a angiofluoresceinografia, a biomicroscopia de fundo e a tomografia de coerência óptica pré e pós-operatórios foram obtidos de todos os pacientes em todas as visitas. No estudo da tomografia de coerência óptica foram avaliadas três características em cada imagem: presença de depressão foveal, presença de edema macular cistóide e média da espessura central macular. RESULTADOS: A idade média dos pacientes foi de 63,3 anos (57 a 78). Cinco pacientes eram do sexo masculino e 5, do sexo feminino. A acuidade visual pré-operatória variou de 20/80 a conta dedos a 1 metro. A acuidade visual melhorou pelo menos duas linhas de visão em 8 olhos (80 por cento) e a metamorfopsia melhorou também na mesma proporção (80 por cento). Quatro pacientes não apresentavam metamorfopsia com a tabela de Amsler, e os demais apresentavam melhora parcial. À tomografia de coerência óptica todos os olhos mantiveram o aumento da espessura central, variando de 232 a 605 µ (média= 351,9 µ). Três olhos mantiveram o edema macular cistóide. Quatro olhos apresentaram acuidade visual final melhor ou igual a 20/30. Neste grupo a média de espessura central foi de 277 µ (265 a 285 µ). A recuperação do contorno foveal foi observada em dois destes olhos. Nos quatro pacientes não havia edema macular cistóide residual. CONCLUSÃO: A tomografia de coerência óptica é uma ferramenta capaz de avaliar as alterações estruturais antes e depois da cirurgia...

PURPOSE: To describe the relation between visual results and macular morphology through optical coherence tomography (OCT) in patients submitted to removal of the idiopathic epiretinal membranes. METHODS: Ten eyes of ten patients with diagnosis of idiopathic epiretinal membranes underwent standard 20-G pars plana vitrectomy. Posterior hyaloid attachments were identified and dealt with. Idiopathic epiretinal membranes were removed in all cases. Corrected visual acuity, retinography, fluorescein angiography, fundus biomicroscopy and the optical coherence tomography in the pre- and postoperative periods were performed in all patients. In OCT, three characteristics were considered in each image: presence of foveal depression, presence of cystoid macular edema and mean central macular thickness. RESULTS: Pre-operative visual acuity varied from 20/80 to counting fingers. The mean age was 63 years, ranging from 57 to 78 years. Five patients were male and five female. Preoperative visual acuity (VA) varied from 20/80 to CD to 1 meter. An improvement in VA of at least two lines was noted in all cases and metamorphopsia in eight eyes (80 percent). Four patients did not present metamorphopsia according to Amsler grid test, and the remaining presented partial improvement. On optical coherence tomography all eyes maintained increased central thickness, ranging from 232 to 605 µ (mean of 351.9 µ). Three eyes maintained cystoid macular edema. Four eyes presented final VA better or equal to 20/30. In this group the mean central thickness was of 277 µ. Foveal contour was recovered in two of these eyes. Four patients had no residual cystoid macular edema. CONCLUSIONS: Optical coherence tomography is a tool that evaluates the structural changes before and after surgery to remove idiopathic epiretinal membranes. Although the foveal area architecture stays irregular six months after surgery, the visual outcomes are very promising. Other prognostics factors...